Private AI company BenevolentAI has announced the appointment of Dr Nathan Brown BSc (Hons) FRSC, as its new Head of Cheminformatics.
The appointment follows the promotion of Mark Davies from Head of Cheminformatics at BenevolentAI to VP Biomedical Informatics earlier this year.
As a a recent recipient of the Corwin Hansch Award for contributions to computational chemistry, Dr Brown has extensive experience as a software designer and has developed many novel algorithms to maximise the impact of the experimental data generated in medicinal chemistry and cancer biology.
Dr Brown joined the Institute of Cancer Research, London, in 2007 where he founded and led the new In Silico Medicinal Chemistry Group which focussed on medicinal chemistry research towards novel cancer treatments. He holds a degree in computing from Robert Gordon University, Aberdeen and conducted his doctoral research in the field of Cheminformatics at the University of Sheffield.
Following his PhD, Dr Brown was awarded a Marie Curie Fellowship for two years working with Avantium in Amsterdam and was subsequently one of the first to be awarded a prestigious Presidential Research Fellowship for three years, by Professor Mark Fishman, Global Head of Research at the Novartis Institutes for BioMedical Research.
Jackie Hunter, CEO of BenevolentBio, the bioscience subsidiary of BenevolentAI, said: “We are delighted to have Nathan on board.”